Growth Unlocked: Epigral Targets Rs 5,000 Crore Revenue by 2031

Aiming for a Rs 5,000 crore revenue target by 2030-31, specialty chemicals player Epigral is aggressively scaling up its Dahej manufacturing base in Gujarat. Under the leadership of CMD Maulik Patel, the company is deploying a Rs 650-crore internal accrual-backed capex to double production lines for both CPVC Resin and ECH. Slated to go live within months, these expansions will significantly boost Epigral's market dominance, making it a global leader in CPVC while reinforcing India's self-reliance through sustainable manufacturing.

News by Rahul Yelligetti.